Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Targeting parasitic histones may improve outcomes in cerebral malaria

Publish date:: April 7, 2019

Key clinical point: Targeting circulating parasitic histones may hold promise for patients with cerebral malaria (CM).

Major finding: Mean circulating histone concentrations were higher in children with retinopathy positive CM (22.6 mcg/ml) than in healthy controls (0.33 mcg/ml).

Study details: A retrospective analysis of patients with cerebral malaria and healthy controls.

Disclosures: The investigators declared no conflicts of interest.

Citation:

Moxon et al. BSH 2019. Abstract OR-034.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Thrombosis

DOACs look safe in elective endoscopic procedures,

Lusutrombopag found safe, effective for severe thrombocytopenia in patients with hepatocellular carcinoma,

HOME-PE trial clarifies which pulmonary embolism patients to treat at home,

Aspirin may accelerate cancer progression in older adults,

Low-dose prasugrel preserves efficacy but lowers bleeding in elderly,